FAST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FAST is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is technically constructive and sentiment is generally supportive, but the setup is already somewhat extended and the near-term downside risk around earnings and margin pressure makes this a hold rather than an immediate buy. If forced to act now, the better choice is to wait for a cleaner entry after earnings.
FAST is in an uptrend: SMA_5 is above SMA_20 and SMA_200, and the MACD histogram is positive and expanding, which confirms bullish momentum. RSI_6 at 77 is elevated, suggesting the stock is somewhat overbought after the recent move. Price at 48.63 is just above pivot 46.959 and nearing resistance at 48.338, with the next resistance at 49.19. This indicates upside is possible, but the stock is already close to resistance and not offering a compelling low-risk entry today.
Fastenal continues to be viewed as a cross-cycle earnings compounder with strong sales growth versus peers. Hedge funds are aggressively buying, and congress trading data also shows 1 recent purchase with no sales, which is a positive signal. Several analysts remain constructive, including Jefferies at Buy with a $52 target and BofA at Buy with a $55 target. Technical momentum is bullish, and the company is heading into Q2 earnings with expectations for continued sales growth.
Insiders have been selling more heavily over the last month, which weakens near-term conviction. DA Davidson initiated coverage at Neutral with a $46 target and flagged margin challenges and slightly high consensus estimates. Bernstein keeps an Underperform rating, citing margin pressure and delayed pricing actions. The stock is near resistance and has an elevated RSI, and the modeled near-term trend shows limited short-term upside with possible weakness over the next month.
No financial snapshot was available, so there is no confirmed latest-quarter reported result to assess directly. The calendar shows Q2 2026 earnings are due on 2026-07-14, with market expectations for EPS of 33 cents and revenue of $2.34 billion. Based on analyst notes, the latest quarter backdrop appears to be one of strong sales growth but margin pressure, with pricing improvements still taking time to show through.
Analyst sentiment is mixed but slightly positive. Recent target changes show multiple raises: Baird to $51, Barclays to $46, and BofA to $55, while DA Davidson initiated Neutral at $46 and Bernstein remains Underperform at $42. Jefferies is bullish at Buy/$52, while Barclays is more cautious at Equal Weight/$46. Overall, Wall Street sees solid long-term operating quality and growth, but near-term margin concerns keep the pros-and-cons view balanced rather than strongly bullish.
